JP2014506249A - グリコフロールを含む経表面局所イソオキサゾリン製剤 - Google Patents

グリコフロールを含む経表面局所イソオキサゾリン製剤 Download PDF

Info

Publication number
JP2014506249A
JP2014506249A JP2013545417A JP2013545417A JP2014506249A JP 2014506249 A JP2014506249 A JP 2014506249A JP 2013545417 A JP2013545417 A JP 2013545417A JP 2013545417 A JP2013545417 A JP 2013545417A JP 2014506249 A JP2014506249 A JP 2014506249A
Authority
JP
Japan
Prior art keywords
methyl
solvent
transsurface
compound
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013545417A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014506249A5 (enExample
Inventor
フツクス，シユテフアン
ヘツケロト，アンヤ・レジーナ
ミユーラー，ラモナ
ビリアムス，ヘイケ
ゾラー，ハルトムート
Original Assignee
インターベツト・インターナシヨナル・ベー・ベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43920659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2014506249(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by インターベツト・インターナシヨナル・ベー・ベー filed Critical インターベツト・インターナシヨナル・ベー・ベー
Publication of JP2014506249A publication Critical patent/JP2014506249A/ja
Publication of JP2014506249A5 publication Critical patent/JP2014506249A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013545417A 2010-12-27 2011-12-22 グリコフロールを含む経表面局所イソオキサゾリン製剤 Pending JP2014506249A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10197090 2010-12-27
EP10197090.3 2010-12-27
US201161430241P 2011-01-06 2011-01-06
US61/430,241 2011-01-06
PCT/EP2011/073830 WO2012089623A1 (en) 2010-12-27 2011-12-22 Topical localized isoxazoline formulation comprising glycofurol

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016138739A Division JP6357508B2 (ja) 2010-12-27 2016-07-13 グリコフロールを含む経表面局所イソオキサゾリン製剤

Publications (2)

Publication Number Publication Date
JP2014506249A true JP2014506249A (ja) 2014-03-13
JP2014506249A5 JP2014506249A5 (enExample) 2015-02-05

Family

ID=43920659

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013545417A Pending JP2014506249A (ja) 2010-12-27 2011-12-22 グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2016138739A Active JP6357508B2 (ja) 2010-12-27 2016-07-13 グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2018115590A Active JP6539384B2 (ja) 2010-12-27 2018-06-18 グリコフロールを含む経表面局所イソオキサゾリン製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016138739A Active JP6357508B2 (ja) 2010-12-27 2016-07-13 グリコフロールを含む経表面局所イソオキサゾリン製剤
JP2018115590A Active JP6539384B2 (ja) 2010-12-27 2018-06-18 グリコフロールを含む経表面局所イソオキサゾリン製剤

Country Status (19)

Country Link
US (2) US20130274302A1 (enExample)
EP (1) EP2658541B2 (enExample)
JP (3) JP2014506249A (enExample)
KR (2) KR101920476B1 (enExample)
CN (2) CN103260620A (enExample)
AU (1) AU2011351579B2 (enExample)
BR (1) BR112013015498A2 (enExample)
CA (1) CA2822853C (enExample)
DK (1) DK2658541T4 (enExample)
ES (1) ES2908254T5 (enExample)
FI (1) FI2658541T4 (enExample)
HU (1) HUE058290T2 (enExample)
MX (2) MX390508B (enExample)
NZ (1) NZ611474A (enExample)
PL (1) PL2658541T5 (enExample)
PT (1) PT2658541T (enExample)
RU (1) RU2602189C2 (enExample)
WO (1) WO2012089623A1 (enExample)
ZA (1) ZA201304515B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022531590A (ja) * 2019-05-03 2022-07-07 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103260620A (zh) * 2010-12-27 2013-08-21 英特维特国际股份有限公司 包含三缩四乙二醇的外用局部异噁唑啉制剂
NZ611476A (en) 2010-12-27 2015-10-30 Intervet Int Bv Topical localized isoxazoline formulation
PT3172964T (pt) 2011-09-12 2020-11-30 Boehringer Ingelheim Animal Health Usa Inc Composições parasiticidas compreendendo um agente ativo de isoxazolina, método e utilizações das mesmas
CN104168900A (zh) 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
JO3626B1 (ar) 2012-02-23 2020-08-27 Merial Inc تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
CA2867079A1 (en) * 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
CN105873925B (zh) 2013-11-01 2019-09-10 勃林格殷格翰动物保健美国公司 抗寄生物的和杀虫的异噁唑啉化合物
EP2875726A1 (fr) * 2013-11-13 2015-05-27 Ceva Animal Health Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites
RU2688167C1 (ru) 2013-12-20 2019-05-20 Интервет Интернэшнл Б.В. Применение изоксазолиновых соединений на домашней птице
JP6581586B2 (ja) * 2013-12-20 2019-09-25 インターベット インターナショナル ベー． フェー． イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
ES2765405T3 (es) 2014-04-17 2020-06-09 Boehringer Ingelheim Animal Health Usa Inc Utilización de compuestos de malononitrilo para proteger animales de parásitos
CA2971296A1 (en) 2014-12-22 2016-06-30 Intervet International B.V. Use of isoxazoline compounds for treating demodicosis
PY1609250A (es) 2015-02-26 2018-03-01 Merial Inc Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
EP3280413A1 (en) 2015-04-08 2018-02-14 Merial, Inc. Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CN110381738B (zh) 2016-10-14 2021-07-16 勃林格殷格翰动物保健美国公司 农药的和杀寄生物的乙烯基异噁唑啉化合物
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
ES2944616T3 (es) 2017-08-14 2023-06-22 Boehringer Ingelheim Animal Health Usa Inc Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas
CA3082048A1 (en) * 2017-11-23 2019-05-31 Ceva Sante Animale Composition containing moxidectin for treating parasites infestations
AR113997A1 (es) 2017-12-21 2020-07-08 Intervet Int Bv Composiciones antiparasitarias para unción dorsal continua
MX2021000293A (es) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos.
EP3883648A1 (en) 2018-11-20 2021-09-29 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
JP7637630B2 (ja) 2019-03-19 2025-02-28 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 駆虫性アザベンゾチオフェンおよびアザベンゾフラン化合物
WO2021010843A1 (en) 2019-07-16 2021-01-21 Donaghys Limited Transdermal solvent system and methods of use
MX2022007455A (es) 2019-12-18 2022-08-15 Elanco Tiergesundheit Ag Derivados de isoxazolina como plaguicidas.
AU2021278871A1 (en) 2020-05-28 2023-01-19 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
PH12022553222A1 (en) 2020-05-29 2024-02-12 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic heterocyclic compounds
JP7724845B2 (ja) 2020-07-24 2025-08-18 エランコ・ユーエス・インコーポレイテッド イソオキサゾリン化合物及びその中間体を作製するための方法
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형
JP2024504208A (ja) 2020-12-21 2024-01-30 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー イソオキサゾリン化合物を含む殺寄生虫首輪
CA3209562A1 (en) 2021-01-27 2022-08-04 Intervet International B.V. Cyclopropylamide compounds against parasites in fish
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
JP7857414B2 (ja) 2022-02-17 2026-05-12 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 流体製品メーラーを提供する方法及びシステム
NO20240925A1 (en) 2023-09-15 2025-03-17 Evah Atlantic Inc Dihydroisoxazole compound for use in reducing ectoparasite infestations on fish
WO2025191150A2 (en) * 2024-03-15 2025-09-18 Krka, D.D., Novo Mesto Stable isoxazoline formulation for topical application to the skin
WO2025257633A1 (en) 2024-06-12 2025-12-18 Boehringer Ingelheim Vetmedica Gmbh Long-acting castor oil-containing injectable formulations and methods of use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123419A (ja) * 1983-11-21 1985-07-02 メイ・アンド・ベーカー・リミテツド 製薬組成物
JP2006522154A (ja) * 2003-04-04 2006-09-28 メリアル リミテッド 動物用駆虫局所製剤
JP2010536733A (ja) * 2007-08-17 2010-12-02 インターベツト・インターナシヨナル・ベー・ベー イソオキサゾリン組成物および駆虫薬としてのそれらの使用
US20100311685A1 (en) * 2007-12-21 2010-12-09 Guy Derrieu Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative And Glycofurol, Use For The Preparation Of A Topical Veterinary Medicament For Combating Fleas

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984564A (en) 1972-06-08 1976-10-05 Sankyo Company Limited Antibiotic substances B-41, their production and their use as insecticides and acaricides
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b and insecticidal compositions containing them
US5399717A (en) 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
US20050192319A1 (en) † 1996-09-19 2005-09-01 Albert Boeckh Spot-on formulations for combating parasites
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
WO2005035088A2 (en) * 2003-07-18 2005-04-21 Baxter International, Inc. Method for preparing small spherical by controlled phase separation
CN101768129B (zh) 2004-03-05 2012-05-23 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物的制备中间体
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
TWI350728B (en) * 2004-10-08 2011-10-21 Wyeth Corp Amitraz compositions
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
HUE037127T2 (hu) 2007-06-27 2018-08-28 Du Pont Állati károkozó irtására szolgáló eljárás
EP2379544B1 (en) 2008-12-18 2013-10-16 Novartis AG Isoxazolines derivatives and their use as pesticide
PL2379537T3 (pl) 2008-12-19 2013-03-29 Elanco Tiergesundheit Ag Pochodne izooksazoliny i ich zastosowanie jako pestycydów
WO2010128095A1 (en) 2009-05-07 2010-11-11 Novartis Ag Ectoparasiticidal compositions
ME02432B (me) 2009-12-17 2016-09-20 Merial Inc Antiparazitska jedinjenja dihidroazola i kompozicije koje ih sadrže
DK178277B1 (da) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
NZ611476A (en) * 2010-12-27 2015-10-30 Intervet Int Bv Topical localized isoxazoline formulation
CN103260620A (zh) * 2010-12-27 2013-08-21 英特维特国际股份有限公司 包含三缩四乙二醇的外用局部异噁唑啉制剂
WO2018039508A1 (en) † 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123419A (ja) * 1983-11-21 1985-07-02 メイ・アンド・ベーカー・リミテツド 製薬組成物
JP2006522154A (ja) * 2003-04-04 2006-09-28 メリアル リミテッド 動物用駆虫局所製剤
JP2010536733A (ja) * 2007-08-17 2010-12-02 インターベツト・インターナシヨナル・ベー・ベー イソオキサゾリン組成物および駆虫薬としてのそれらの使用
US20100311685A1 (en) * 2007-12-21 2010-12-09 Guy Derrieu Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative And Glycofurol, Use For The Preparation Of A Topical Veterinary Medicament For Combating Fleas

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6016009692; 医薬品添加物ハンドブック , 2007, ｐ．２６３-２６４ *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022531590A (ja) * 2019-05-03 2022-07-07 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用
JP7558197B2 (ja) 2019-05-03 2024-09-30 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用
JP2024170642A (ja) * 2019-05-03 2024-12-10 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用
JP7769070B2 (ja) 2019-05-03 2025-11-12 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用

Also Published As

Publication number Publication date
ES2908254T3 (es) 2022-04-28
DK2658541T4 (da) 2026-02-23
NZ611474A (en) 2015-08-28
PL2658541T5 (pl) 2026-03-02
MX348079B (es) 2017-05-25
DK2658541T3 (da) 2022-04-04
PT2658541T (pt) 2022-03-11
MX2013007501A (es) 2013-08-01
FI2658541T4 (fi) 2026-03-12
MX390508B (es) 2025-03-20
JP6539384B2 (ja) 2019-07-03
RU2602189C2 (ru) 2016-11-10
JP2018154657A (ja) 2018-10-04
CA2822853C (en) 2021-05-11
KR20130130762A (ko) 2013-12-02
MX2019011837A (es) 2019-11-21
US20130274302A1 (en) 2013-10-17
JP6357508B2 (ja) 2018-07-11
JP2016216489A (ja) 2016-12-22
KR101992589B1 (ko) 2019-06-24
CA2822853A1 (en) 2012-07-05
KR20180125618A (ko) 2018-11-23
CN103260620A (zh) 2013-08-21
ES2908254T5 (en) 2026-04-13
EP2658541B1 (en) 2022-01-26
HUE058290T2 (hu) 2022-07-28
PL2658541T3 (pl) 2022-04-04
EP2658541A1 (en) 2013-11-06
AU2011351579A1 (en) 2013-06-20
BR112013015498A2 (pt) 2016-11-01
CN108125951A (zh) 2018-06-08
US20150011596A1 (en) 2015-01-08
WO2012089623A1 (en) 2012-07-05
EP2658541B2 (en) 2025-12-17
KR101920476B1 (ko) 2018-11-21
AU2011351579B2 (en) 2016-04-21
ZA201304515B (en) 2014-03-26
RU2013135415A (ru) 2015-02-10

Similar Documents

Publication Publication Date Title
JP6357508B2 (ja) グリコフロールを含む経表面局所イソオキサゾリン製剤
JP6246864B2 (ja) 経表面局所イソオキサゾリン製剤
KR102193090B1 (ko) 국소 적용 이속사졸린 제제

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141212

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160112

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160315